Increased serum IL-8 levels were associated with CAC and sarcopenia in patients with pancreatic cancer, as evidenced by a study involving resected (n = 91) and locally advanced (LA) groups (n = 55). Here, CXCL8 is linked to pancreatic neoplasm.